The neurobiology and genetics of Attention-Deficit/Hyperactivity Disorder (ADHD): What every clinician should know (Q22252222)

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Overview of animal models of attention deficit hyperactivity disorder (ADHD).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Genome-wide association scan of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Abnormal cerebral cortex structure in children with ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Enhanced neural activity in frontal and cerebellar circuits after cognitive training in children with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Is the ADHD brain wired differently? A review on structural and functional connectivity in attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Training-induced neuroanatomical plasticity in ADHD: A tensor-based morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Molecular genetics of attention-deficit/hyperactivity disorder: an overview

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

European guidelines on managing adverse effects of medication for ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Quantitative electroencephalography and attention-deficit/hyperactivity disorder: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

New insights into attention-deficit/hyperactivity disorder using structural neuroimaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Molecular genetics of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Attention-deficit/hyperactivity disorder: a preliminary diffusion tensor imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Cingulate-precuneus interactions: a new locus of dysfunction in adult attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Diffusion tensor imaging study of white matter fiber tracts in pediatric bipolar disorder and attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Atypical default network connectivity in youth with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

The macrostructural and microstructural abnormalities of corpus callosum in children with attention deficit/hyperactivity disorder: a combined morphometric and diffusion tensor MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Neuroimaging of attention deficit hyperactivity disorder: can new imaging findings be integrated in clinical practice?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

The neurobiology of attention deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Measured gene-by-environment interaction in relation to attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Twin studies and their implications for molecular genetic studies: endophenotypes integrate quantitative and molecular genetics in ADHD research.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Reduced activation and inter-regional functional connectivity of fronto-striatal networks in adults with childhood Attention-Deficit Hyperactivity Disorder (ADHD) and persisting symptoms during tasks of motor inhibition and cognitive switching.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Spontaneous attentional fluctuations in impaired states and pathological conditions: a neurobiological hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Dopamine transporter gene variation modulates activation of striatum in youth with ADHD

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Structural MRI of pediatric brain development: what have we learned and where are we going?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Neurobiology of ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Molecular genetics of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Differential fractional anisotropy abnormalities in adolescents with ADHD or schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Behavioral performance predicts grey matter reductions in the right inferior frontal gyrus in young adults with combined type ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Structural and functional imaging approaches in attention deficit/hyperactivity disorder: does the temporal lobe play a key role?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Comparison of a standard psychiatric evaluation to rating scales and EEG in the differential diagnosis of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

P300 deficits in adults with attention deficit hyperactivity disorder: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Gene X environment interactions in reading disability and attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Rethinking shared environment as a source of variance underlying attention-deficit/hyperactivity disorder symptoms: comment on Burt (2009).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naïve boys with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Heritability in the genomics era — concepts and misconceptions

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

A default mode of brain function

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Spectroscopic findings in attention-deficit/hyperactivity disorder: review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Magnetic Resonance Imaging of Boys With Attention-Deficit/Hyperactivity Disorder and Their Unaffected Siblings

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Widespread cortical thinning is a robust anatomical marker for attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Reduced white matter integrity in attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Editorial: ADHD as a reinforcement disorder - moving from general effects to identifying (six) specific models to test.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Prediction of individual brain maturity using fMRI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Attention deficit disorder with developmental coordination disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Update on the use of MR for assessment and diagnosis of psychiatric diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Cerebellar development and clinical outcome in attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Frontostriatal connectivity and its role in cognitive control in parent-child dyads with ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Amygdala activation during emotion processing of neutral faces in children with severe mood dysregulation versus ADHD or bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Morphological abnormalities of the thalamus in youths with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Cortical development in typically developing children with symptoms of hyperactivity and impulsivity: support for a dimensional view of attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Neuroimaging in attention-deficit hyperactivity disorder: beyond the frontostriatal circuitry

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

The restless brain: attention-deficit hyperactivity disorder, resting-state functional connectivity, and intrasubject variability

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Stimulant medication and prefrontal functional connectivity during working memory in ADHD: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Utility of the Electroencephalogram in Attention Deficit Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Structural brain change in Attention Deficit Hyperactivity Disorder identified by meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Discriminating between ADHD adults and controls using independent ERP components and a support vector machine: a validation study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Neurobiology of attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Clinical utility of EEG in attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

The search for biomarkers for attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Etiologic Classification of Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

The genetics of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

Pharmacogenetic approach for a better drug treatment in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021

A current update on ADHD pharmacogenomics

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPN.2012.01.009

7 January 2021